Report: Medtronic establishes $35m settlement fund for Synchromed pumps

Report: Medtronic establishes $35m settlement fund for Synchromed pumps

Source: 
Mass Device
snippet: 

Medtronic (NYSE:MDT) last week reportedly agreed to create a settlement fund worth some $35 million to compensate those who say they were harmed by the SynchroMed II intrathecal drug pump.